Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM.
Mareike GastlVera LachmannAikaterini ChristidiNico JanzarikVerena VeulemansSebastian HaberkornLeonie HolzbachChristoph JacobyBernhard SchnackenburgSusanne Berrisch-RahmelTobias ZeusMalte KelmFlorian BönnerPublished in: European radiology (2020)
• Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete's may add information to distinguish athlete's heart from pathologic left ventricular hypertrophy.
Keyphrases
- left ventricular
- heart failure
- hypertrophic cardiomyopathy
- neoadjuvant chemotherapy
- high resolution
- magnetic resonance
- magnetic resonance imaging
- cardiac resynchronization therapy
- acute myocardial infarction
- locally advanced
- aortic stenosis
- high density
- mitral valve
- left atrial
- contrast enhanced
- computed tomography
- squamous cell carcinoma
- machine learning
- mass spectrometry
- radiation therapy
- lymph node
- percutaneous coronary intervention
- acute coronary syndrome